Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2009-8-21
pubmed:abstractText
Evidence-based guidelines for immunization of infants, children, adolescents, and adults have been prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). These updated guidelines replace the previous immunization guidelines published in 2002. These guidelines are prepared for health care professionals who care for either immunocompetent or immunocompromised people of all ages. Since 2002, the capacity to prevent more infectious diseases has increased markedly for several reasons: new vaccines have been licensed (human papillomavirus vaccine; live, attenuated influenza vaccine; meningococcal conjugate vaccine; rotavirus vaccine; tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis [Tdap] vaccine; and zoster vaccine), new combination vaccines have become available (measles, mumps, rubella and varicella vaccine; tetanus, diphtheria, and pertussis and inactivated polio vaccine; and tetanus, diphtheria, and pertussis and inactivated polio/Haemophilus influenzae type b vaccine), hepatitis A vaccines are now recommended universally for young children, influenza vaccines are recommended annually for all children aged 6 months through 18 years and for adults aged > or = 50 years, and a second dose of varicella vaccine has been added to the routine childhood and adolescent immunization schedule. Many of these changes have resulted in expansion of the adolescent and adult immunization schedules. In addition, increased emphasis has been placed on removing barriers to immunization, eliminating racial/ethnic disparities, addressing vaccine safety issues, financing recommended vaccines, and immunizing specific groups, including health care providers, immunocompromised people, pregnant women, international travelers, and internationally adopted children. This document includes 46 standards that, if followed, should lead to optimal disease prevention through vaccination in multiple population groups while maintaining high levels of safety.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1537-6591
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
817-40
pubmed:dateRevised
2009-12-24
pubmed:meshHeading
pubmed-meshheading:19659433-Adolescent, pubmed-meshheading:19659433-Adult, pubmed-meshheading:19659433-Child, pubmed-meshheading:19659433-Child, Preschool, pubmed-meshheading:19659433-Communicable Disease Control, pubmed-meshheading:19659433-Ethnic Groups, pubmed-meshheading:19659433-Female, pubmed-meshheading:19659433-Humans, pubmed-meshheading:19659433-Immunization Programs, pubmed-meshheading:19659433-Immunization Schedule, pubmed-meshheading:19659433-Immunocompromised Host, pubmed-meshheading:19659433-Infant, pubmed-meshheading:19659433-Infant, Newborn, pubmed-meshheading:19659433-Infectious Disease Medicine, pubmed-meshheading:19659433-Male, pubmed-meshheading:19659433-Pregnancy, pubmed-meshheading:19659433-Travel, pubmed-meshheading:19659433-Vaccination, pubmed-meshheading:19659433-Young Adult
pubmed:year
2009
pubmed:articleTitle
Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
pubmed:affiliation
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. LPickering@cdc.gov
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Practice Guideline